Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Khaled Mohamed Nassar
Institutions:
The University of Texas at San Antonio Health Science Center,
The University of Texas at San Antonio
Observed institutions:
The University of Texas at San Antonio Health Science Center,
The University of Texas at San Antonio
ORCID:
0000-0001-5510-2838
Observed ORCID:
0000-0001-5510-2838
OpenAlex ID:
A5042298551
PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
·
Cancer Research Communications
·
5
ERX-208 Induces Endoplasmic Reticulum Stress and Suppresses DNA Damage Repair to Enhance Chemotherapy Sensitivity
2026
·
Durga Meenakshi Panneerdoss
, Khaled Mohamed Nassar
, et al.
·
Cancer Research Communications
PDF
Abstract 1260: LIPA inhibition enhances the therapeutic efficacy of DNA-damaging agents in ovarian cancer through induction of ER stress and enhancing DNA damage.
2026
·
Durga Meenakshi Panneerdoss
, Tae-Kyung Lee
, et al.
·
Cancer Research
Targeting LIPA with ERX-41 Induces ER Stress and Inhibits Tumor Progression in Inflammatory Breast Cancer
2026
·
Zenaida Fuentes
, Gaurav Sharma
, et al.
·
Biomolecules
Supplementary Table 1 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2025
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Supplementary Figure 1 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2025
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Supplementary Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2025
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Data from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Figure 3 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Figure 1 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Figure 5 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Supplementary Figure 1 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Supplementary Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
PDF
Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Figure 4 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
Supplementary Table 1 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma
2024
·
Khaled Mohamed Nassar
, Xue Yang
, et al.
PDF
Show more works
View as search
Works count:
16
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type